Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 2/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | COMT | P21964 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2540575 | 0.82 | POLB (0.43) | POLBNPSR1NQO1CYP1A2CYP2C9 | |
| SCHEMBL10915289 | 0.71 | ATAD2 (0.38) | POLBNPSR1NQO1KMT2AALDH1A1 | |
| SCHEMBL28167081 | 0.70 | ESR1 (0.42) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL10915873 | 0.70 | ATAD2 (0.36) | POLBNPSR1NQO1KMT2AALDH1A1 | |
| SCHEMBL25164695 | 0.67 | POLB (0.33) | POLBNPSR1NQO1 | |
| SCHEMBL8957061 | 0.67 | IDH1 (0.37) | CYP1A2CYP2C9KMT2ACOMTALDH1A1 | |
| SCHEMBL13402630 | 0.67 | KDM4E (0.39) | TYRCYP2C9COMTALDH1A1DAO | |
| SCHEMBL8894016 | 0.67 | POLB (0.55) | POLBNPSR1TYRCYP1A2CYP2C9 | |
| SCHEMBL17980826 | 0.65 | KDM4E (0.42) | CYP1A2CYP2C9KMT2AALDH1A1 | |
| SCHEMBL20026452 | 0.65 | KDM4E (0.47) | TYRCYP2C9COMTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2026-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | KLK3, FOLH1, PSMA1 | POLB 3628/4885NPSR1 81/4885TYR 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.